Audit 5957

FY End
2023-06-30
Total Expended
$1.24B
Findings
6
Programs
487
Organization: University of Pennsylvania (PA)
Year: 2023 Accepted: 2023-12-08

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
3772 2023-002 - Yes I
3773 2023-001 - - E
3774 2023-002 - Yes I
580214 2023-002 - Yes I
580215 2023-001 - - E
580216 2023-002 - Yes I

Programs

ALN Program Spent Major Findings
84.268 Federal Direct Loans $215.48M - 0
93.498 Covid-19 - Provider Relief Fund $19.01M Yes 0
84.038 Perkins Loan Outstanding Loans Issued As July 1, 2022 $16.57M - 0
93.342 Hpl Dental Outstanding As of 07/01/2022 $11.01M - 0
93.RD Niaid Centers of Excellence for Influenza Research and Response $8.06M Yes 0
93.RD Integrated Informatics Resources for Eukaryotic Microbial Pathogens An $5.74M Yes 0
47.041 Covid-19 - Engineering $5.13M Yes 0
93.364 Nursing Student Loan Undergraduate Outstanding Loans Issued As of 07/01/2022 $3.32M - 0
93.342 Health Professions Student Loans, Including Primary Care Loans/loans for Disadvantaged Students $2.72M - 0
93.264 Nurse Faculty Loan Program Outstanding As of 07/01/22 $2.48M - 0
93.342 Lds Medical Outstanding As of 07/01/2022 $2.39M - 0
12.RD Scutle (sociocultural Understanding Through Linguistic Expression) $2.05M Yes 0
93.RD Inhalation Toxicology of Chlorine Gas-on-A-Chip $1.69M Yes 0
93.505 Affordable Care Act (aca) Maternal, Infant, and Early Childhood Home Visiting Program $1.68M - 0
93.RD Preclinical Vector Production Core Laboratory $1.65M Yes 0
93.847 Covid-19 - Diabetes, Digestive, and Kidney Diseases Extramural Research $1.57M Yes 0
12.910 Covid-19 - Research and Technology Development $1.31M Yes 0
12.RD Corpora of Annotated Events Represented Under Schemas (caerus) $1.20M Yes 0
93.RD Civics – Component A $1.17M Yes 0
12.RD Starkpepper $1.11M Yes 0
20.RD National Sleep Study Technical Support $1.02M Yes 0
12.RD Pausit: Privacy Protection and Authorship Attribution Using Style-Base $924,158 Yes 0
98.RD Internews - Inspires Project $859,594 Yes 0
12.351 Basic Scientific Research - Combating Weapons of Mass Destruction $789,614 Yes 0
93.342 Hpl Dental Issued After 07/01/2022 $777,764 - 0
93.084 Covid-19 - Prevention of Disease, Disability, and Death by Infectious Diseases $776,633 Yes 0
93.RD Assessment of the Efficacy of Acute Pain Treatments: An Rtc Re-Analysi $764,302 Yes 0
12.RD Integrated Static and Dynamic Approaches to High-Assurance for Learnin $732,896 Yes 0
16.738 Edward Byrne Memorial Justice Assistance Grant Program $685,078 - 0
12.RD Restoring Memory with Task-Independent Semi-Chronic Closed-Loop Direct $610,547 Yes 0
12.RD Collective Lifelong Learning by Distributed Agents $601,680 Yes 0
93.318 Covid-19 - Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $580,125 Yes 0
93.225 National Research Service Awards_health Services Research Training $532,914 Yes 0
93.364 Nursing Student Loan Graduate Outstanding Loans Issued As of 07/01/2022 $522,103 - 0
93.RD Covid-19 - A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Sa $515,488 Yes 0
12.RD Cairo-Ms: Conflicting Account Information Resources in Omnivorous Medi $484,542 Yes 0
16.609 Project Safe Neighborhoods $474,148 Yes 0
93.866 Covid-19 - Aging Research $462,699 Yes 0
84.027 Special Education_grants to States $446,715 - 0
12.RD Systemic Generative Engineering $442,459 Yes 0
12.RD Top Gated 2d/alscn/sic Structures for Surface Acoustic Wave Amplifiers $434,532 Yes 0
12.RD Better Extraction From Text Towards Enhanced Retrieval (better) $430,626 Yes 0
93.117 Preventive Medicine Residency $418,009 Yes 0
93.173 Covid-19 - Research Related to Deafness and Communication Disorders $401,469 Yes 0
93.011 Covid-19 - National Organizations of State and Local Officials $392,920 Yes 0
93.264 Nurse Faculty Loan Program Issued During Fy23 $390,395 - 0
21.027 Covid-19 - Coronavirus State and Local Fiscal Recovery Funds $371,951 - 0
93.RD Beat-Hiv: Delaney Collaboratory to Cure Hiv-1 Infection by Combination $365,391 Yes 0
12.RD Integrated Quantum Inspired Photonic Solver (i-Qips) $350,229 Yes 0
93.RD Spore in Skin Cancer (project 1) $332,127 Yes 0
93.RD Continued Assessment of the Efficacy of Chronic Opioid Pain Treatments $328,139 Yes 0
93.RD Covid-19 - Secondary Infections and Antibiotic Resistance in Post-Acute Care Pati $324,141 Yes 0
93.342 Hpl Vet Issued After 07/01/2022 $317,200 - 0
93.RD A Scalable, Patient-Centered Approach for "right-Sizing" Opioid Prescr $316,512 Yes 0
97.RD Detection Canine Sciences, Innovation, Technology and Education (dcsit $311,065 Yes 0
84.287 Twenty-First Century Community Learning Centers $310,292 - 0
47.070 Covid-19 - Computer and Information Science and Engineering $303,926 Yes 0
81.RD Research for Atlas Experiment $303,711 Yes 0
12.400 Military Construction, National Guard $302,503 Yes 0
84.044 Trio_talent Search $302,473 - 0
93.732 Mental and Behavioral Health Education and Training Grants $300,990 Yes 0
84.033 Federal Work-Study Program $300,792 - 0
93.RD Quantitative Analysis of Longitudinal Mr Images in Blsa Participants $294,329 Yes 0
93.945 Assistance Programs for Chronic Disease Prevention and Control $291,716 Yes 0
93.350 Covid-19 - National Center for Advancing Translational Sciences $282,765 Yes 0
93.364 Nursing Student Loan Undergraduate New Loans Issued During 2023 $279,327 - 0
93.RD Evidence-Based Practice Centers - Ahrq Epc Vi Idiq Contract $277,988 Yes 0
12.RD Behavioral Characterization of Odor Detection Dogs for Selection of PO $275,682 Yes 0
93.884 Grants for Primary Care Training and Enhancement $273,025 Yes 0
12.RD Ferroelectric Aluminum Scandium Nitride Memory Devices and Integration $270,822 Yes 0
93.047 American Indian Chronic Renal Insufficiency Cohort Study – Ai-Cric $252,973 Yes 0
47.RD Harnessing Evolution to Reveal the Molecular Logic of Kinetochore Wiri $243,711 Yes 0
93.877 Autism Collaboration, Accountability, Research, Education, and Support $243,438 Yes 0
84.042 Trio_student Support Services $242,911 - 0
93.859 Covid-19 - Biomedical Research and Research Training $236,368 Yes 0
16.U14 Doj, Antitrust Division (atr) - Intergovernmental Personnel Act (ipa) $232,693 - 0
93.RD Covid-19 - Mfmu Maternal Morbidity and Mortality During the Covid-19 Pandemic $231,735 Yes 0
12.RD Task-And-User Aware Representation Learning for Fine Grained Crossling $230,064 Yes 0
47.074 Covid-19 - Biological Sciences $228,862 Yes 0
10.561 State Administrative Matching Grants for the Supplemental Nutrition Assistance Program $222,829 - 0
20.701 University Transportation Centers Program $222,548 Yes 0
93.RD Option 23: Multivalent Influenza Mrna Vaccines $219,808 Yes 0
93.667 Social Services Block Grant $219,317 - 0
12.RD High-Band Operation Via Periodic Structures (hops) $216,999 Yes 0
12.RD Hr001121s0007-08 : Third-Party Verification of Cots Software Complianc $208,058 Yes 0
12.RD Energy-Efficient Vision-Based Navigation Through Event-Based Sensing A $203,752 Yes 0
16.746 Capital Case Litigation Initiative $203,701 Yes 0
45.164 Promotion of the Humanities_public Programs $200,000 - 0
93.778 Dhs - Resource & Referral Tool $200,000 - 0
93.435 Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke- $196,961 Yes 0
94.013 Volunteers in Service to America $193,709 - 0
64.RD Bioactive Injectable Implants for Functional Interverterbral Disc Rege $192,132 Yes 0
12.RD Linking Investigations in Trauma and Emergency Services (lites) $190,519 Yes 0
16.575 Crime Victim Assistance $189,047 - 0
16.RD Upholding the Rule of Law and Preventing Wrongful Convictions Training $179,230 Yes 0
93.059 Training in General, Pediatric, and Public Health Dentistry $179,107 Yes 0
64.RD Va Merit Award: Immune and Genetic Controls of Tissue Regeneration in $178,374 Yes 0
64.RD Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk $178,226 Yes 0
93.994 Maternal and Child Health Services Block Grant to the States $175,000 - 0
64.RD Tissue Engineered Total Disc Replacement in A Large Animal Model $173,417 Yes 0
81.RD Deep Underground Neutrino Experiment (dune) $169,813 Yes 0
12.RD Hypothesis-Guided Model Revision Over Multiple Aligned Representations $169,581 Yes 0
93.RD Instructor Led Training on Pharmacoepidemiology $167,071 Yes 0
93.310 Covid-19 - Trans-Nih Research Support $164,444 Yes 0
64.RD Impact of Overload and Overuse Following Subscapularis Tears: Mechanis $162,662 Yes 0
93.226 Covid-19 - Research on Healthcare Costs, Quality and Outcomes $162,446 Yes 0
81.RD Tailoring Photophysical Energy Transfer for Selective Separations of C $161,772 Yes 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $159,100 - 0
19.025 U.s. Ambassadors Fund for Cultural Preservation $156,370 - 0
12.RD Liquid-Fuel Thermionic Battlefield Generators $155,862 Yes 0
47.RD Sbir Phase Ii: Single Wearable Patch for Cost-Effective, Reliable, and $149,401 Yes 0
81.RD Center for 3d Ferroelectric Microelectronics $146,846 Yes 0
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $144,686 - 0
64.RD Knee Joint Resurfacing with Anatomic Tissue Engineered Osteochondral I $139,739 Yes 0
47.RD Ipa Agreement - Program Director in the Robust Intelligence Program $138,564 Yes 0
93.RD Clinical Evaluation of Nestorone (nes) and Testosterone (t) Combinatio $138,421 Yes 0
93.RD Population Health Research Support - Study of Pregnancy and Neonatal H $137,463 Yes 0
12.RD Self-Reconfigurable Modular Ground Robots $137,255 Yes 0
93.U13 Fy23 Samhsa-Perc Fep $135,531 - 0
81.RD Eos Detector $135,301 Yes 0
93.342 Hpl Medical Outstanding As of 07/01/2022 $133,177 - 0
12.RD Secure Handling of Isolated Executables Without Leaking (closure). $130,631 Yes 0
16.582 Crime Vicitim Assistance/discretionary Grants $130,588 - 0
64.RD Preferences Elicited and Respected for Seriously Ill Veterans Through $128,264 Yes 0
12.RD Circulating Cfdna Fragments for the Detection and Diagnosis of Traumat $125,905 Yes 0
93.262 Occupational Safety and Health Program $124,773 Yes 0
93.RD Ultrasensitive Psa Quantitation Using Smartphone to Reduce Prostate Ca $123,717 Yes 0
64.RD Va Ipa Baofeng Hu & Vu Nguyen - Va Merit $117,714 Yes 0
15.676 Youth Engagement, Education, and Employment Programs $117,663 - 0
12.RD Aluminum Scandium Nitride Mems Pdk $117,415 Yes 0
93.686 Ending the Hiv Epidemic: A Plan for America $113,286 - 0
93.924 Ryan White Hiv/aids Dental Reimbursement and Community Based Dental Partnership Grants $112,019 - 0
93.088 Advancing System Improvements for Key Issues in Women's Health $111,297 Yes 0
93.116 Project Grants and Cooperative Agreements for Tuberculosis Control Programs $108,871 - 0
20.109 Air Transportation Centers of Excellence $105,726 Yes 0
12.351 Covid-19 - Basic Scientific Research - Combating Weapons of Mass Destruction $104,328 Yes 0
47.079 Office of International Science and Engineering $101,815 Yes 0
84.063 Federal Pell Grant Program $100,914 - 0
64.RD Transplantable Micro-Tissue Engineered Neural Networks to Restore the $100,807 Yes 0
64.RD Va Ipa: Lauraellen Ashcraft $100,638 Yes 0
93.RD Covid-19 - Medical Imaging and Data Resource Center (midrc) for Rapid Response to $100,000 Yes 0
64.RD Covid-19 - Covid-19: Understanding the Role of Corona Virus Induced Disruption of $97,787 Yes 0
12.RD Contour Based Image Segmentation Sttr Phase II $97,680 Yes 0
64.RD Va Ipa: Anthony Davis (pcchw)-Ffy 2022 $96,435 Yes 0
64.RD Va Ipa: Randy Hastings (pcchw)-Ffy 2022 $96,434 Yes 0
93.RD Clinical and Molecular Determinants of Transmission of Esbls in the CO $95,048 Yes 0
93.RD Hypertrophic Cardiomyopathy: Understanding the Heterogeneity of Diseas $94,477 Yes 0
64.RD Beers - Va Merit Award $93,439 Yes 0
97.036 Covid-19 - Fema Public Assistance Grants $93,236 - 0
81.RD Multi-Source Learning-Accelerated Design of High-Efficiency Multi-Stag $92,902 Yes 0
64.RD Ipa #1, Chang-Mvp (m. Vujkovic)no Restricts Non-U.s. Entity Participat $92,823 Yes 0
81.RD Research for Atlas Experiment - Trt Subsystem $92,318 Yes 0
64.RD Pathologic Signaling Pathways in Aml Cells $91,452 Yes 0
47.084 Transforming Educational Technology Through Convergence $89,980 Yes 0
93.RD Mechanical Device for the Prevention of Vte in High Risk Patient Popul $89,548 Yes 0
93.RD Drcr Retina Network - Protocol Af $86,543 Yes 0
93.RD Covid-19 - Medical Imaging and Data Consortium: Rapid Response to Covid-19 Pandem $84,629 Yes 0
93.279 Covid-19 - Drug Abuse and Addiction Research Programs $84,605 Yes 0
12.RD Improving Neurotrauma by Depolarization Inhibition with Combination Th $84,170 Yes 0
64.RD Va Ipa-Aneeza Agha $83,014 Yes 0
98.RD Cultural Change for Transparency Office of the Attorney General of the $82,978 Yes 0
84.184 Safe and Drug-Free Schools and Communities_national Programs $82,443 Yes 0
14.913 Office of Lead Hazard Control and Healthy Homes $79,957 - 0
84.047 Trio_upward Bound $78,370 - 0
64.RD Problem Solving Therapy Program Ipa: Gregory Brown and Kelly Green $78,346 Yes 0
93.391 Activities to Support State, Tribal, Local and Territorial (stlt) Health Department Response to Public Health Or Healthcare Crises $77,754 - 0
64.RD The Role of Disc Nutrition in the Etiology and Clinical Treatment of D $75,867 Yes 0
84.305 Covid-19 - Education Research, Development and Dissemination $75,080 Yes 0
21.027 Covid -19 - Coronavirus State and Local Fiscal Recovery Funds $75,000 - 0
12.RD Multiferroic Vector Magnetometer (mfvm) $74,909 Yes 0
81.RD Atoms-To-Systems CO-Design: Transforming Data Flow to Accelerate Scien $74,108 Yes 0
93.048 Special Programs for the Aging_title Iv_and Title Ii_discretionary Projects $73,445 - 0
94.006 Americorps $72,726 - 0
93.919 Cooperative Agreements for State-Based Comprehensive Breast and Cervical Cancer Early Detection Programs $72,002 - 0
93.217 Family Planning_services $72,000 - 0
93.RD Upcc35419: Clinical Transplant-Related Long-Term Outcomes of Alternati $71,761 Yes 0
10.310 Covid-19 - Agriculture and Food Research Initiative (afri) $70,936 Yes 0
64.RD Covid-19 - Caleigh Doherty Csp Va Ipa $69,302 Yes 0
12.RD Constrained Tomography with Undersampled Projections $69,038 Yes 0
12.RD Transforming Research and Clinical Knowledge in Traumatic Brain Injury $68,827 Yes 0
43.012 Space Technology $68,731 Yes 0
93.RD Covid-19 - Impact of Local Differences in Vaccine Uptake on Sars-Cov-2 Evolution $67,455 Yes 0
64.RD Va Ipa: Denerale Jones (pcchw-Ffy 2022) $66,708 Yes 0
93.RD Allosteric Impact of Non-Active-Site Mutations on Enzymatic Function $66,282 Yes 0
19.021 Investing in People in the Middle East and North Africa $65,764 Yes 0
64.RD Sdr: Genomic Analysis of Blast Tube Induced Tbi in Mice $63,460 Yes 0
10.RD Maintenance of Membership Laboratory Requirements $63,446 Yes 0
64.RD Va Ipa: Jingyi Wu (project Number: 1i01hx003345-01a2) $63,212 Yes 0
11.619 Arrangements for Interdisciplinary Research Infrastructure $62,346 Yes 0
64.RD Va Ipa Agreement for Sofia Lizza $62,344 Yes 0
93.RD Hpv Point of Care Molecular Diagnostics for Lmics $61,884 Yes 0
93.RD A Lateral Flow Assay for Rapid Saliva Fentanyl Detection (efentanyl) $60,234 Yes 0
93.RD Pk and Safety of Commonly Used Drugs in Lactating Women and Breastfed $59,475 Yes 0
11.609 Measurement and Engineering Research and Standards $59,372 Yes 0
81.RD Itk Dicing $59,296 Yes 0
64.RD The Role of Functional Iron Deficiency in Systemic Complications of Ck $59,235 Yes 0
81.RD Non-Proliferation Anti-Neutrino Research $59,136 Yes 0
93.351 Research Infrastructure Programs $58,812 Yes 0
81.RD Pipeline Infrastructure Operations Personnel Effort for the Lsst Dark $58,197 Yes 0
64.RD Ipa Anita Agarwal Vast-D-II Study $57,474 Yes 0
84.022 Overseas Programs - Doctoral Dissertation Research Abroad $57,336 Yes 0
64.RD Immunologic Mechanisms for Heterogeneity of Cutaneous Lupus Erythemato $56,816 Yes 0
93.RD A Rapid Microfluidic Diagnostic Assay for the Measurement of Direct Or $56,142 Yes 0
93.RD Promoting and Supporting Innovation in Tanf Data $55,609 Yes 0
93.365 Sickle Cell Treatment Demonstration Program $54,545 Yes 0
93.RD Maintenance of the Innovation Center (ic) $54,235 Yes 0
47.078 Polar Programs $53,910 Yes 0
64.U16 Va Ipa: Franya Hutchins-Patient Aligned Care Team (pact) Mou $53,042 - 0
93.078 Strengthening Emergency Care Delivery in the United States Healthcare System Through Health Information and Promotion $52,398 Yes 0
64.RD Traumatic and Treatable Vascular Pathology in the Outcome of Tbi $51,273 Yes 0
12.RD Design and Production of 3 New Mrna Production Plasmid $50,000 Yes 0
93.590 Child Abuse Prevention Program $50,000 - 0
47.RD Mustang 2 Operations on the Green Bank Telescope $49,610 Yes 0
93.321 Dietary Supplement Research Program $48,815 Yes 0
64.RD Ipa # 2 Chang R&d (m. Vujkovic) $48,695 Yes 0
42.U08 Using Primary Sources to Support Civically Engaged Argument Writing in $48,322 - 0
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $45,877 Yes 0
64.RD Ipa for Saewhan Park - Racial Bias in A Va Algorithm for High-Risk Vet $45,692 Yes 0
64.RD Covid-19 - Tammy Xu Fy22 Covid Ipa $45,306 Yes 0
64.RD Optimization of Engineered Endplates to Improve in Vivo Integration of $45,045 Yes 0
64.RD Ipa for Nayeli Nunez Cruz on "cognitive Behavioral Therapy for Insomni $44,559 Yes 0
64.RD Covid-19 - Covid-19: Elucidating the Role of the Nasal Epithelium in Sars-Cov-2 I $43,336 Yes 0
64.RD Ipa - Statins and Cirrhosis: Reducing Events of Decompensation (sacred $42,193 Yes 0
93.RD Covid-19 - Food Insecurity, Neighborhood Environment, and Weight Trajectories in $41,187 Yes 0
19.U15 Ipa for Eugen Dimant, Associate Fellow for the Office of Evaluation Sc $40,909 - 0
81.RD Shape Changing of Responsive Elastomer Structures (scores) $40,889 Yes 0
93.778 Medical Assistance Program $40,176 - 0
93.U02 Ipa Assignment Agreement $39,874 - 0
64.RD Ipa for K. Linn and J. Yan $39,600 Yes 0
45.312 National Leadership Grants $39,481 Yes 0
64.RD Evidence Based Psychotherapy Program $39,006 Yes 0
93.RD Pharmacological Targeting of Galpha Subunits in Disease $38,694 Yes 0
64.RD Brown,lily - Sayers: Suicide Prevention Services Integration in Coachi $36,817 Yes 0
11.417 Sea Grant Support $36,757 Yes 0
64.RD Covid-19 - Fy23 Ipa Lea Williams Csp $36,539 Yes 0
93.RD Development of A Prototype Software for Automated Pet/ct Interpretatio $36,261 Yes 0
64.RD Va Merit - Steltz Ipa $35,908 Yes 0
64.U19 Ipa: Hummy Song (improving Post-Acute Care Value for Veterans - I01hx0 $34,558 - 0
12.RD Electromechanical Components for Efficient, Small Scale Power Conversi $33,863 Yes 0
93.RD Covid-19 - Whole-Genome Sequencing to Define Sars-Cov-2 Variant Populations Durin $33,749 Yes 0
93.342 Lds Medical Issud After 07/01/2022 $32,177 - 0
64.RD Year 1 Ipas for Mauck/burdick Va Spire Project: "hydrogel Delivery of $31,793 Yes 0
64.RD Ipa # 4, Mvp035covid Vujkovic $31,384 Yes 0
12.RD Thermionic Power Generation for Individual Soldier $31,307 Yes 0
93.556 Promoting Safe and Stable Families $31,085 - 0
93.914 Hiv Emergency Relief Project Grants $30,712 Yes 1
64.RD Va Ipa: Aileen Oon $30,526 Yes 0
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $30,301 - 0
93.940 Hiv Prevention Activities_health Department Based $30,062 - 0
64.RD Evaluate the Role of Cgas in the Type I Interferon Response Elicited B $30,000 Yes 0
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $29,801 - 0
93.RD Consultant to the Toolbox Project: Learning, Evaluation and Research C $29,696 Yes 0
64.RD Covid-19 - Ipa for Mary Valiga - Csp 2028 $29,261 Yes 0
64.RD Va Ipa Agreement for Alex Burdzy $29,194 Yes 0
93.103 Covid-19 - Food and Drug Administration_research $28,483 Yes 0
81.RD Advancement of Bulk Acoustic Wave Devices Using Strategically Poled Ac $28,452 Yes 0
43.RD Neid Guaranteed-Time Observing (gto) $28,316 Yes 0
12.RD Soluble Receptor Proteins for Screening Assays $28,289 Yes 0
64.RD Ipa - Holly Barilla to Deliver Cbt for Insomnia in Patients with Serio $28,033 Yes 0
66.511 Office of Research and Development Consolidated Research/training/fellowships $27,950 Yes 0
64.RD Neural Processing of Multisensory Speech at Millisecond and Millimeter $27,866 Yes 0
64.RD Living Electrodes for Auditory Rehabilitation $27,294 Yes 0
64.RD Ipa Lynch Mirecc $27,198 Yes 0
93.364 Nursing Student Loan Graduate Outstanding New Loans Issued During 2022 $27,158 - 0
93.307 Covid-19 - Minority Health and Health Disparities Research $27,023 Yes 0
64.RD Cartilage Repair Strategies to Alleviate Arthritis Pain (care Ap): Tar $27,020 Yes 0
64.RD Development of A Molecular Imaging System for Surgical Specimen Imagin $26,951 Yes 0
64.RD Extracellular Vesicles As A Novel Mediator for Ultraviolet-B Light Ind $26,580 Yes 0
98.RD Sbar Cambodia Solid Waste Accountability Platform (swap) $26,562 Yes 0
64.RD Va Ipa for Daniel Traum $26,270 Yes 0
93.RD Development and Evaluation of A Chlorhexidine Gluconate Bathing Protoc $26,244 Yes 0
81.RD High Performance Electromechanical Filters Realized in Highly Doped Al $26,119 Yes 0
93.RD Covid-19 - Rapid and Ultra-Sensitive Sars-Cov-2 Antigen Detection for Acute Infec $26,071 Yes 0
10.207 Animal Health and Disease Research $25,824 Yes 0
64.RD Covid-19 - Bijal Patel Fy23 Covid Ipa $25,778 Yes 0
81.RD Future Relevance of Proton and Flash Radiotherapy to the Ors Mission $25,032 Yes 0
93.084 Prevention of Disease, Disability, and Death by Infectious Diseases $24,991 Yes 0
64.RD Va Ipa: Jingyi Wu (cardiovascular Care and Outcomes for Veterans Exper $24,850 Yes 0
14.RD Fy 2022 and Fy 2023 Community Compass Technical Assistance and Capacit $24,724 Yes 0
64.RD Ipa Agreement for Xavier Arthur $22,908 Yes 0
45.301 Museums for America $22,816 - 0
64.RD Juliana Bonilla Fy23 Csp Ipa $22,485 Yes 0
93.RD Upcc08421: Phase II Multi-Center Trial of Anti-B Cell Maturation Antig $21,375 Yes 0
14.536 Covid-19 - Research and Evaluations, Demonstrations, and Data Analysis and Utilization $21,237 Yes 0
93.RD Hiv Prevention and Care Project: Intersectional Stigma Reduction Inter $21,003 Yes 0
94.RD Covid-19 - Enhancing the Public Health Response to Domestic Violence in the Conte $20,823 Yes 0
16.RD Evaluation of the Police Assisted Diversion Pilot in Philadelphia $20,476 Yes 0
64.RD Lynch Prime Ipa $20,113 Yes 0
12.RD Human Interpretable Attribution of Text Using Underlying Structure (hi $19,910 Yes 0
81.RD Characterization of Nanocrystalline Diamond Capsules $19,730 Yes 0
64.RD Covid-19 - Va Ipa Agreement for Mary Valiga (dr. Isaacs) 3/6/23-9/30/23 $19,508 Yes 0
64.RD Va Ipa Agreement for Mary Valiga (jhala) 03/06/2023-09/30/2023 $19,508 Yes 0
81.RD Design of A Target and Dichroicon for Photon Sorting at Chess $19,349 Yes 0
64.RD Samuel Kline Ipa - Does Adding A Tailored Cognitive Behavioral Therapy $19,134 Yes 0
64.RD Tissue Engineered Nigrostriatal Pathway As A Testbed for Evaluating Ax $19,088 Yes 0
93.647 Social Services Research and Demonstration $18,854 Yes 0
12.RD Bio-Fabricated Nerve-Muscle Complexes to Augment Regeneration and Faci $18,629 Yes 0
64.RD Va Ipa: Molly Knowles (pcchw-Ffy 2022) $18,599 Yes 0
93.RD Treatment for Mixed Urinary Incontinence: Mid-Urethral Sling Vs. Botox $18,393 Yes 0
93.421 Covid-19 - Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $18,296 Yes 0
12.RD Penn Aerospace Club: Aerospace Propulsion Outreach Program $18,249 Yes 0
12.RD Uncover: Cross-Lingual Question Answering to Identifying Information D $18,202 Yes 0
64.RD Covid-19 - Va Ipa: Kristin Linn $18,099 Yes 0
64.RD Ipa Agreement for Sofia Lizza $17,954 Yes 0
93.917 Aids Programs & Special Pharmacy Services $17,521 - 0
11.619 Covid-19 - Arrangements for Interdisciplinary Research Infrastructure $17,218 Yes 0
43.003 Exploration $16,796 Yes 0
64.RD Va Ipa: Ravishankar Jayadevappa (visn Project) $16,497 Yes 0
64.RD Covid-19 - Jayana Richardson Covid Ipa $16,313 Yes 0
64.U17 Va Ipa for Kevin Lynch $16,232 - 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $15,773 Yes 0
64.RD Va Ipa: Rucha Kandlur (pcchw-Ffy 2022) $15,549 Yes 0
64.RD Ipa for Michael Perlis - Cognitive Behavioral Therapy (cbt-I) Augmenta $15,411 Yes 0
64.RD Ipa for Samuel Kline Csp 2016 Study $15,324 Yes 0
93.307 Minority Health and Health Disparities Research $15,053 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $14,926 Yes 0
64.RD Covid-19 - Lea Williams Covid-19 Ipa $14,879 Yes 0
64.RD Julianna Bonilla Ipa for Va Merit Fy23 $14,786 Yes 0
64.RD Developing Personalized Medicine Strategies to Increase Physical Activ $14,775 Yes 0
19.RD Updating Measures of Low-Value Care in Medicare $14,476 Yes 0
64.RD Va Ipa: Ankitha Rao (pcchw-Ffy 2022) $14,211 Yes 0
64.RD Ipa Kember-Mvp004 $14,056 Yes 0
81.RD Data-Driven Fluid Mechanics: Learning Rheology From Flow Visualization $13,642 Yes 0
64.RD Va Ipa: Genevieve Kanter (project Number: 1i01hx003345-01a2) $13,483 Yes 0
64.RD Ipa for Elizabeth Krizman $13,285 Yes 0
93.RD Covid-19 - at Home Microbubbling Sars-Cov-2 Antigen Test $13,004 Yes 0
93.361 Covid-19 - Nursing Research $12,855 Yes 0
93.RD Task Order 1 - Contraceptive Development Program Nichd Contraceptive C $12,684 Yes 0
64.RD Ipa for Dr. Voight Participation in Study "genetics of Cardiometabolic $12,154 Yes 0
43.008 Education $12,000 Yes 0
64.RD Ipa for Zeal Jinwala: Analysis of Data From the Million Veteran Progra $11,814 Yes 0
84.324 Research in Special Education $11,807 Yes 0
47.084 Pfi-Rp: Compliant Manipulation of Small, Delicate, and Curved Objects $11,593 Yes 0
93.RD Bacterial Interference to Prevent Staphylococcus Aureus Infection $11,498 Yes 0
64.RD Neuromodulation As A Therapy for Ptsd Following Chronic Tbi $11,376 Yes 0
93.RD Acf Data Governance Consulting and Support Extension Contract $11,325 Yes 0
64.RD Ipa Agreement for Melissa Naschek $10,983 Yes 0
47.083 Integrative Activities $10,981 Yes 0
93.RD Enhancing Treg Therapeutic Efficacy in Gvhd $10,677 Yes 0
93.397 Cancer Centers Support Grants $10,636 Yes 0
93.RD Covid-19 - A Multicenter, Adaptive, Randomized Controlled Platform Trial of the S $10,387 Yes 0
64.RD Ipa - Keith Bredemeier $10,251 Yes 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $10,125 Yes 0
64.RD Covid-19 - Tammy Xu Csp #2028 Ipa $10,021 Yes 0
64.RD Accelerated Aging As A Cause of Chronic Lung Allograft Dysfunction $10,007 Yes 0
93.136 Overdose Fatality Review $10,000 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $9,949 - 0
93.569 Community Services Block Grant $9,944 - 0
19.040 Public Diplomacy Programs $9,900 - 0
64.U06 Va/ipa Agreements for Mary Valiga, James Keith and Xiaowang Qu $9,754 - 0
84.015 National Resource Centers Program for Foreign Language and Area Studies Or Foreign Language and International Studies Program and Foreign Language and Area Studies Fellowship Program $9,596 - 0
93.226 Research on Healthcare Costs, Quality and Outcomes $9,587 Yes 0
93.839 Covid-19 - Blood Diseases and Resources Research $9,447 Yes 0
64.U09 Cognitive Behavioral Therapy (cbt-I) Augmentation of Topiramate in Pro $9,443 - 0
93.172 Covid-19 - Human Genome Research $9,369 Yes 0
12.RD Environmentally Sustainable Analysis and Design Support and Monitoring $9,291 Yes 0
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $8,987 - 0
43.RD Foam Optics and Mechanics $8,931 Yes 0
64.RD Ipa - Richard Crist (gamma) $8,572 Yes 0
98.001 Usaid Foreign Assistance for Programs Overseas $7,993 Yes 0
64.RD Pathogenesis of Chronic Rhinosinusitis $7,932 Yes 0
19.019 International Programs to Combat Human Trafficking $7,484 Yes 0
81.RD Hybrid Quantum/classical Algorithms for Photochemistry and Nonadiabati $7,132 Yes 0
64.RD Fy23 Bijal Patel Ipa for Baker Va Merit $7,016 Yes 0
93.838 Covid-19 - Lung Diseases Research $6,543 Yes 0
93.RD Master Plan for Integration of Innovation Technologies and Ic $6,363 Yes 0
45.025 Promotion of the Arts_partnership Agreements $6,300 - 0
93.U01 Occupational and Emergency Medicine Content Development and Technical $6,257 - 0
93.RD Covid-19 - Building Covid-19 Vaccine Confidence Among Nursing Students, Nurses, A $5,890 Yes 0
43.002 Aeronautics $5,854 Yes 0
64.RD Cognitive Behavioral Therapy (cbt-I) Augmentation of Topiramate in Pro $5,816 Yes 0
47.050 Geosciences $5,627 Yes 0
66.203 Environmental Finance Center Grants $5,520 - 0
12.RD Acoustoelectric Amplifiers for Efficient Radio Frequency Signal Proces $5,507 Yes 0
93.RD Upcc 03422: A Phase 3, Randomized, Open-Label, Multicenter Study, to C $5,447 Yes 0
20.215 Highway Training and Education $5,078 Yes 0
12.RD Non-Invasive Monitoring of Traumatic Brain Injury Progression Using Th $4,968 Yes 0
64.RD Va Ipa: Phoebe Whiteside (va Queri Grant) $4,888 Yes 0
64.RD Translational Modeling of Brain Injury Rehabilitation to Maximize Reco $4,845 Yes 0
12.RD Cross-Domain Transfer Learning $4,802 Yes 0
64.U07 Va Ipa for Kevin Lynch $4,636 - 0
64.RD Va Ipa: Rebecca Hubbard (visn Project) $4,470 Yes 0
93.213 Research and Training in Complementary and Integrative Health $4,381 Yes 0
12.RD Sttr: Vectorization Solutions to Make Decisions About Objects and Area $4,316 Yes 0
64.RD Phenotypic and Genomic Architecture of Cardiovascular Disease Subtypes $4,235 Yes 0
93.669 Child Abuse and Neglect State Grants $4,121 - 0
19.345 International Programs to Support Democracy, Human Rights and Labor $4,120 Yes 0
15.958 Route 66 Corridor Preservation $3,970 Yes 0
64.RD Covid-19 - Va Ipa: Tamar Klaiman $3,850 Yes 0
43.007 Space Operations $3,784 Yes 0
84.379 Teacher Education Assistance for College and Higher Education Grants (teach Grants) $3,772 - 0
64.RD Queri Sage Ipa $3,654 Yes 0
16.834 Vicitims of Child Pornography & Trafficking $3,580 - 0
84.007 Federal Supplemental Educational Opportunity Grants $3,500 - 0
93.RD Nucleoside-Modified Mrna Vaccination to Induce Hemagglutinin Stalk-Spe $3,487 Yes 0
45.169 Promotion of the Humanities_office of Digital Humanities $3,458 - 0
64.RD Chronic Focal and Diffuse Traumatic Brain Injury: Mechanisms Underlyin $3,118 Yes 0
93.394 Covid-19 - Cancer Detection and Diagnosis Research $2,984 Yes 0
84.021 Overseas Programs - Group Projects Abroad $2,762 - 0
12.RD H6 Tactical-Grade Clock $2,529 Yes 0
12.RD Dod Phase II Sttr 12.a, Topic No. A12a-T009 $2,443 Yes 0
45.161 Promotion of the Humanities_research $2,430 Yes 0
64.RD Ipa for Kristin Linn $2,379 Yes 0
93.879 Covid-19 - Medical Library Assistance $2,262 Yes 0
93.865 Covid-19 - Child Health and Human Development Extramural Research $2,257 Yes 0
93.575 Child Care and Development Block Grant $2,087 - 0
81.RD Removable Adhesives $2,054 Yes 0
93.853 Covid-19 - Extramural Research Programs in the Neurosciences and Neurological Disorders $1,818 Yes 0
64.RD Group (“project Life Force”) Vs. Individual Suicide Safety Planning Rc $1,817 Yes 0
93.RD Rapid Point of Care Molecular Diagnostics of Hcv $1,537 Yes 0
64.RD Mechano-Active Annular Repair Device for Treating Disc Herniation $1,428 Yes 0
93.113 Environmental Health $1,237 Yes 0
43.001 Science $983 Yes 0
10.001 Agricultural Research_basic and Applied Research $884 Yes 0
84.305 Education Research, Development and Dissemination $817 Yes 0
47.075 Covid-19 - Social, Behavioral, and Economic Sciences $771 Yes 0
12.630 Basic, Applied, and Advanced Research in Science and Engineering $686 Yes 0
93.855 Covid-19 - Allergy, Immunology and Transplantation Research $251 Yes 0
93.172 Human Genome Research $169 Yes 0
93.958 Block Grants for Community Mental Health Services $37 - 0
47.076 Covid-19 - Education and Human Resources $7 Yes 0
12.750 Uniformed Services University Medical Research Projects $2 Yes 0
45.024 Promotion of the Arts_grants to Organizations and Individuals $1 - 0
64.RD Development of A Unique in Vitro Test Bed Model to Explore Mechanisms $-2 Yes 0
93.393 Cancer Cause and Prevention Research $-20 Yes 0
10.310 Agriculture and Food Research Initiative (afri) $-25 Yes 0
93.186 National Research Service Award in Primary Care Medicine $-39 Yes 0
12.RD Neurobehavioral Effects of Battlemind Vs. Mindfulness Based Military T $-103 Yes 0
16.560 National Institute of Justice Research, Evaluation, and Development Project Grants $-141 Yes 0
12.RD Sonicviper $-147 Yes 0
93.RD Covid-19 - the Impact of Sars-Cov-2 Infection During Pregnancy on Obstetric and N $-672 Yes 0
93.398 Cancer Research Manpower $-674 Yes 0
81.RD Itk Strips Assembly and Testing $-693 Yes 0
47.075 Social, Behavioral, and Economic Sciences $-946 Yes 0
93.361 Nursing Research $-1,082 Yes 0
93.989 International Research and Research Training $-1,382 Yes 0
93.103 Food and Drug Administration_research $-1,401 Yes 0
93.266 Health Systems Strengthening and Hiv/aids Prevention, Care and Treatment Under the President's Emergency Plan for Aids Relief $-1,727 Yes 0
93.121 Oral Diseases and Disorders Research $-2,171 Yes 0
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $-2,359 Yes 0
47.076 Education and Human Resources $-2,659 Yes 0
10.025 Plant and Animal Disease, Pest Control, and Animal Care $-2,960 Yes 0
47.041 Engineering $-3,672 Yes 0
93.879 Medical Library Assistance $-3,672 Yes 0
12.910 Research and Technology Development $-4,143 Yes 0
47.070 Computer and Information Science and Engineering $-4,987 Yes 0
81.049 Office of Science Financial Assistance Program $-5,180 Yes 0
15.945 Cooperative Research and Training Programs Ð Resources of the National Park System $-6,197 Yes 0
93.279 Drug Abuse and Addiction Research Programs $-7,745 Yes 0
12.431 Basic Scientific Research $-8,532 Yes 0
81.086 Conservation Research and Development $-8,883 Yes 0
93.242 Covid-19 - Mental Health Research Grants $-8,928 Yes 0
64.RD Va Ipa: Jingyi Wu (racial and Ethnic Differences in Presentation and Q $-9,305 Yes 0
12.420 Military Medical Research and Development $-9,449 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $-9,705 Yes 0
93.310 Trans-Nih Research Support $-10,282 Yes 0
93.273 Alcohol Research Programs $-10,445 Yes 0
93.399 Cancer Control $-11,210 Yes 0
93.837 Covid-19 - Cardiovascular Diseases Research $-11,387 Yes 0
93.RD Activity in Women at Risk for Early Delivery (aware). An Ancillary Stu $-12,257 Yes 0
81.135 Advanced Research Projects Agency - Energy $-14,865 Yes 0
93.395 Cancer Treatment Research $-16,291 Yes 0
12.800 Air Force Defense Research Sciences Program $-17,046 Yes 0
47.049 Mathematical and Physical Sciences $-17,417 Yes 0
93.855 Allergy, Immunology and Transplantation Research $-20,882 Yes 0
93.867 Vision Research $-21,367 Yes 0
43.001 Covid-19 - Science $-21,901 Yes 0
93.173 Research Related to Deafness and Communication Disorders $-26,559 Yes 0
93.242 Mental Health Research Grants $-26,911 Yes 0
12.300 Basic and Applied Scientific Research $-27,707 Yes 0
64.RD Tissue-Engineered Constructs for Treatment of Intervertebral Disc Dege $-29,442 Yes 0
47.074 Biological Sciences $-33,876 Yes 0
93.866 Aging Research $-43,134 Yes 0
12.RD Robust Autonomy in Uavs on A Convergent Digital-Analog Ferroelectronic $-48,990 Yes 0
93.859 Biomedical Research and Research Training $-49,365 Yes 0
93.350 National Center for Advancing Translational Sciences $-51,172 Yes 0
93.788 Opioid Str $-56,387 - 0
93.837 Cardiovascular Diseases Research $-59,241 Yes 0
93.394 Cancer Detection and Diagnosis Research $-96,388 Yes 0
93.233 National Center on Sleep Disorders Research $-99,013 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $-102,559 Yes 0
93.838 Lung Diseases Research $-111,725 Yes 0
93.839 Blood Diseases and Resources Research $-119,178 Yes 0
93.865 Child Health and Human Development Extramural Research $-127,262 Yes 0
93.396 Cancer Biology Research $-153,487 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $-225,935 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $-285,648 Yes 0

Contacts

Name Title Type
GM1XX56LEP58 Susie Won Auditee
2155736706 William Liva Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: The Schedule of Expenditures of Federal Awards (the “Schedule”) has been prepared to present a summary of those activities of the University of Pennsylvania for the year ended June 30, 2023, which have been financed by the U.S. Government (“Federal awards”) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Relegations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). For purposes of the Schedule, Federal awards include all Federal assistance entered into directly between the University of Pennsylvania and the Federal government and sub-awards from non- Federal organizations made under federally sponsored agreements. Because the Schedule presents only a selected portion of the activities of the University of Pennsylvania, it is not intended to and does not present the financial position or the revenues, expenses or changes in net assets of the University of Pennsylvania. De Minimis Rate Used: N Rate Explanation: The University applies its predetermined approved facilities and administrative rate when charging indirect costs to federal awards rather than the 10% de minimis cost rate as described in Section 200.414 of the Uniform Guidance. The Schedule of Expenditures of Federal Awards (the “Schedule”) has been prepared to present a summary of those activities of the University of Pennsylvania for the year ended June 30, 2023, which have been financed by the U.S. Government (“Federal awards”) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Relegations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). For purposes of the Schedule, Federal awards include all Federal assistance entered into directly between the University of Pennsylvania and the Federal government and sub-awards from non- Federal organizations made under federally sponsored agreements. Because the Schedule presents only a selected portion of the activities of the University of Pennsylvania, it is not intended to and does not present the financial position or the revenues, expenses or changes in net assets of the University of Pennsylvania. The University applies its predetermined approved facilities and administrative rate when charging indirect costs to federal awards rather than the 10% de minimis cost rate as described in Section 200.414 of the Uniform Guidance. Negative amounts on the schedule represent adjustments in the normal course of business to amounts reported in previous years. Assistance Listing and pass-through award numbers are presented where available.
Title: Federal Student Financial Assistance Accounting Policies: The Schedule of Expenditures of Federal Awards (the “Schedule”) has been prepared to present a summary of those activities of the University of Pennsylvania for the year ended June 30, 2023, which have been financed by the U.S. Government (“Federal awards”) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Relegations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). For purposes of the Schedule, Federal awards include all Federal assistance entered into directly between the University of Pennsylvania and the Federal government and sub-awards from non- Federal organizations made under federally sponsored agreements. Because the Schedule presents only a selected portion of the activities of the University of Pennsylvania, it is not intended to and does not present the financial position or the revenues, expenses or changes in net assets of the University of Pennsylvania. De Minimis Rate Used: N Rate Explanation: The University applies its predetermined approved facilities and administrative rate when charging indirect costs to federal awards rather than the 10% de minimis cost rate as described in Section 200.414 of the Uniform Guidance. The federal student loan programs included within the Student Financial Aid Cluster on the Schedule of Expenditures of Federal Awards above, with the exception of Federal Direct Loans, are administered directly by the University and balances and transactions relating to these programs are included in the University’s consolidated financial statements. Loans outstanding at the beginning of the year and loans made during the year are included in the federal expenditures presented in the Schedule. The amounts of Federal Loans outstanding as of June 30, 2023 are shown on below. Federal Grantor/Program Assistance Listing Number Outstanding Balance as of 6/30/2023 Department of Education Perkins Loan 84.038 9,206,415 Department of Health and Human Services Health Professions Student Loans - Dental 93.342 10,930,488 Health Professions Student Loans - Medical 93.342 121,177 Health Professions Student Loans - Vet 93.342 2,965,861 Loans for Disadvantaged Students - Medical 93.342 2,252,804 Nursing Student Loan - Graduate 93.364 466,861 Nurse Faculty Loan Program 93.264 2,553,502 Nursing Student Loan - Undergraduate 93.364 3,138,696
Title: Federal Emergency Management Agency (“FEMA”) Accounting Policies: The Schedule of Expenditures of Federal Awards (the “Schedule”) has been prepared to present a summary of those activities of the University of Pennsylvania for the year ended June 30, 2023, which have been financed by the U.S. Government (“Federal awards”) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Relegations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). For purposes of the Schedule, Federal awards include all Federal assistance entered into directly between the University of Pennsylvania and the Federal government and sub-awards from non- Federal organizations made under federally sponsored agreements. Because the Schedule presents only a selected portion of the activities of the University of Pennsylvania, it is not intended to and does not present the financial position or the revenues, expenses or changes in net assets of the University of Pennsylvania. De Minimis Rate Used: N Rate Explanation: The University applies its predetermined approved facilities and administrative rate when charging indirect costs to federal awards rather than the 10% de minimis cost rate as described in Section 200.414 of the Uniform Guidance. As of June 30, 2023, the University received approval for $5.7M of claims submitted to FEMA during 2023 under Assistance Listing Number 97.036. The claims submitted represented incurred expenses attributed to the University’s response to COVID-19. The fiscal year 2023 Schedule includes expenses of $5.7M which were incurred in a prior year.

Finding Details

2023-002 Procurement, Suspension and Debarment Federal Grantor: Department of Health and Human Services and Department of Defense Program: Research and Development Cluster Assistance Listing Title: Extramural Research Programs in the Neurosciences and Neurological Disorders; Military Medical Research and Development Assistance Listing Number: 93.853, 12.420 Award Year: 7/1/2022 - 6/30/2023 Award Number: 1-DP2-NS-111996-01, W81XWH2010901 Pass-through Entity: Not applicable Pass-through Number: Not applicable Criteria Per 2 CFR section 180.220, non-federal entities are prohibited from contracting with or making subawards under covered transactions, where vendor purchases exceed $25,000, to parties that are suspended or debarred. When a non-federal entity enters into a covered transaction, the non-federal entity must verify that the vendor is not suspended or debarred or otherwise excluded from participating in the transaction. This verification may be accomplished by (1) checking the System for Award Management (SAM) Exclusions maintained by the General Services Administration (GSA) and available at SAM.gov, (2) collecting a certification from the Vendor, or (3) adding a clause or condition to the covered transaction with that Vendor. University’s policies mirror the procurement policies as required by the Federal government, and defines a covered transaction as purchases exceeding $10,000. Condition In testing compliance with the suspension and debarment compliance requirement, 2 instances of 25 samples selected for testing were noted where the only evidence available to support the date of the performance of the required suspension and debarment checks was after the transaction date, as shown in the chart below. This is a repeat of prior year finding 2022-002. [table] Cause There are no questioned costs associated with this finding.The University uses Visual Compliance (VC) for suspension and debarment checks, which was implemented in 2019. Vendors onboarded prior to the implementation were registered and checked via a separate manual process within the procurement department. The above vendors were on-boarded and checked prior to the VC implementation; however, management could not provide evidence that the vendor check was performed prior to conducting business with the vendor due to the manual nature of the legacy process. Management has subsequently performed checks on these vendors and retained documentation of the checks to validate that the vendors are not currently suspended or debarred. Effect If procedures related to vendor suspended and debarred checks are not performed timely, there is a risk that the purchases could be made with a suspended or debarred vendor. Questioned Costs There are no questioned costs associated with this finding. Recommendation We recommend the University continue to follow its corrective action plan. Management’s View and Corrective Action Plan Management’s view and corrective action plan is included at the end of this report.
2023-001 Eligibility Federal Grantor: Department of Health and Human Services, Health Resources and Services Administration (“HRSA”) Pass-through Entity: City of Philadelphia, AIDS Activity Coordinating Office (“AACO”) Assistance Listing Title: HIV Emergency Relief Project Grants – Outpatient/Ambulatory Medical Care Assistance Listing Number: 93.914 Award Year: 2023 Award Number: RW2965 Pass-through Number: 2120575-01 Criteria Per the Ryan White Client Certification Form Instructions provided to management by the AIDS Activity Coordinating Office, “The certification process must begin for all clients upon initial intake for services and final eligibility is determined once all supporting documentation has been received and verified.” Additionally, the form states that copy of all documentation are to be retained by the provider. The City of Philadelphia Subrecipient Audit Guide Section 6130.04 provides a list of documents to be maintained and states “case management service providers are required to keep a file on each client served.” Further, per the Universal Monitoring Standards set forth by HRSA, the Ryan White HIV/AIDS Program Part A and B Monitoring Standards require service providers who receive Ryan White funding to screen to certify eligibility for Ryan White-funded services. The guidance states that documentation of eligibility determination is required in client records, as evidenced by copies of documents. Condition We reviewed a sample of 65 program participants to verify eligibility during the fiscal year. Of the 65 selected, there were 6 program participants at the Wood Clinic within the Clinical Care Associates of the University of Pennsylvania Health System (“Health System”) in which the Health System did not maintain Ryan White certification cards as documentation evidencing the control in place to certify the verification of the program participant’s eligibility. However, for all 6 program participants, the Health System provided records to support that the program participant met the eligibility requirements. Cause Management of the Health System noted that the AACO program at the Wood Clinic ended in November 2022 and the individuals involved in the process did not maintain the documentation evidencing that management verified participant eligibility in the program. Effect Program participants accepted into the program may be ineligible and the Health System may not be able to demonstrate eligibility of the participants. Questioned Costs None Recommendation The Health System should ensure that all individuals involved in the Ryan White certification process are educated that documentation is required to be maintained to support verification of program participant eligibility. Management’s View and Corrective Action Plan Management’s view and corrective action plan is included at the end of this report.
2023-002 Procurement, Suspension and Debarment Federal Grantor: Department of Health and Human Services and Department of Defense Program: Research and Development Cluster Assistance Listing Title: Extramural Research Programs in the Neurosciences and Neurological Disorders; Military Medical Research and Development Assistance Listing Number: 93.853, 12.420 Award Year: 7/1/2022 - 6/30/2023 Award Number: 1-DP2-NS-111996-01, W81XWH2010901 Pass-through Entity: Not applicable Pass-through Number: Not applicable Criteria Per 2 CFR section 180.220, non-federal entities are prohibited from contracting with or making subawards under covered transactions, where vendor purchases exceed $25,000, to parties that are suspended or debarred. When a non-federal entity enters into a covered transaction, the non-federal entity must verify that the vendor is not suspended or debarred or otherwise excluded from participating in the transaction. This verification may be accomplished by (1) checking the System for Award Management (SAM) Exclusions maintained by the General Services Administration (GSA) and available at SAM.gov, (2) collecting a certification from the Vendor, or (3) adding a clause or condition to the covered transaction with that Vendor. University’s policies mirror the procurement policies as required by the Federal government, and defines a covered transaction as purchases exceeding $10,000. Condition In testing compliance with the suspension and debarment compliance requirement, 2 instances of 25 samples selected for testing were noted where the only evidence available to support the date of the performance of the required suspension and debarment checks was after the transaction date, as shown in the chart below. This is a repeat of prior year finding 2022-002. [table] Cause There are no questioned costs associated with this finding.The University uses Visual Compliance (VC) for suspension and debarment checks, which was implemented in 2019. Vendors onboarded prior to the implementation were registered and checked via a separate manual process within the procurement department. The above vendors were on-boarded and checked prior to the VC implementation; however, management could not provide evidence that the vendor check was performed prior to conducting business with the vendor due to the manual nature of the legacy process. Management has subsequently performed checks on these vendors and retained documentation of the checks to validate that the vendors are not currently suspended or debarred. Effect If procedures related to vendor suspended and debarred checks are not performed timely, there is a risk that the purchases could be made with a suspended or debarred vendor. Questioned Costs There are no questioned costs associated with this finding. Recommendation We recommend the University continue to follow its corrective action plan. Management’s View and Corrective Action Plan Management’s view and corrective action plan is included at the end of this report.
2023-002 Procurement, Suspension and Debarment Federal Grantor: Department of Health and Human Services and Department of Defense Program: Research and Development Cluster Assistance Listing Title: Extramural Research Programs in the Neurosciences and Neurological Disorders; Military Medical Research and Development Assistance Listing Number: 93.853, 12.420 Award Year: 7/1/2022 - 6/30/2023 Award Number: 1-DP2-NS-111996-01, W81XWH2010901 Pass-through Entity: Not applicable Pass-through Number: Not applicable Criteria Per 2 CFR section 180.220, non-federal entities are prohibited from contracting with or making subawards under covered transactions, where vendor purchases exceed $25,000, to parties that are suspended or debarred. When a non-federal entity enters into a covered transaction, the non-federal entity must verify that the vendor is not suspended or debarred or otherwise excluded from participating in the transaction. This verification may be accomplished by (1) checking the System for Award Management (SAM) Exclusions maintained by the General Services Administration (GSA) and available at SAM.gov, (2) collecting a certification from the Vendor, or (3) adding a clause or condition to the covered transaction with that Vendor. University’s policies mirror the procurement policies as required by the Federal government, and defines a covered transaction as purchases exceeding $10,000. Condition In testing compliance with the suspension and debarment compliance requirement, 2 instances of 25 samples selected for testing were noted where the only evidence available to support the date of the performance of the required suspension and debarment checks was after the transaction date, as shown in the chart below. This is a repeat of prior year finding 2022-002. [table] Cause There are no questioned costs associated with this finding.The University uses Visual Compliance (VC) for suspension and debarment checks, which was implemented in 2019. Vendors onboarded prior to the implementation were registered and checked via a separate manual process within the procurement department. The above vendors were on-boarded and checked prior to the VC implementation; however, management could not provide evidence that the vendor check was performed prior to conducting business with the vendor due to the manual nature of the legacy process. Management has subsequently performed checks on these vendors and retained documentation of the checks to validate that the vendors are not currently suspended or debarred. Effect If procedures related to vendor suspended and debarred checks are not performed timely, there is a risk that the purchases could be made with a suspended or debarred vendor. Questioned Costs There are no questioned costs associated with this finding. Recommendation We recommend the University continue to follow its corrective action plan. Management’s View and Corrective Action Plan Management’s view and corrective action plan is included at the end of this report.
2023-001 Eligibility Federal Grantor: Department of Health and Human Services, Health Resources and Services Administration (“HRSA”) Pass-through Entity: City of Philadelphia, AIDS Activity Coordinating Office (“AACO”) Assistance Listing Title: HIV Emergency Relief Project Grants – Outpatient/Ambulatory Medical Care Assistance Listing Number: 93.914 Award Year: 2023 Award Number: RW2965 Pass-through Number: 2120575-01 Criteria Per the Ryan White Client Certification Form Instructions provided to management by the AIDS Activity Coordinating Office, “The certification process must begin for all clients upon initial intake for services and final eligibility is determined once all supporting documentation has been received and verified.” Additionally, the form states that copy of all documentation are to be retained by the provider. The City of Philadelphia Subrecipient Audit Guide Section 6130.04 provides a list of documents to be maintained and states “case management service providers are required to keep a file on each client served.” Further, per the Universal Monitoring Standards set forth by HRSA, the Ryan White HIV/AIDS Program Part A and B Monitoring Standards require service providers who receive Ryan White funding to screen to certify eligibility for Ryan White-funded services. The guidance states that documentation of eligibility determination is required in client records, as evidenced by copies of documents. Condition We reviewed a sample of 65 program participants to verify eligibility during the fiscal year. Of the 65 selected, there were 6 program participants at the Wood Clinic within the Clinical Care Associates of the University of Pennsylvania Health System (“Health System”) in which the Health System did not maintain Ryan White certification cards as documentation evidencing the control in place to certify the verification of the program participant’s eligibility. However, for all 6 program participants, the Health System provided records to support that the program participant met the eligibility requirements. Cause Management of the Health System noted that the AACO program at the Wood Clinic ended in November 2022 and the individuals involved in the process did not maintain the documentation evidencing that management verified participant eligibility in the program. Effect Program participants accepted into the program may be ineligible and the Health System may not be able to demonstrate eligibility of the participants. Questioned Costs None Recommendation The Health System should ensure that all individuals involved in the Ryan White certification process are educated that documentation is required to be maintained to support verification of program participant eligibility. Management’s View and Corrective Action Plan Management’s view and corrective action plan is included at the end of this report.
2023-002 Procurement, Suspension and Debarment Federal Grantor: Department of Health and Human Services and Department of Defense Program: Research and Development Cluster Assistance Listing Title: Extramural Research Programs in the Neurosciences and Neurological Disorders; Military Medical Research and Development Assistance Listing Number: 93.853, 12.420 Award Year: 7/1/2022 - 6/30/2023 Award Number: 1-DP2-NS-111996-01, W81XWH2010901 Pass-through Entity: Not applicable Pass-through Number: Not applicable Criteria Per 2 CFR section 180.220, non-federal entities are prohibited from contracting with or making subawards under covered transactions, where vendor purchases exceed $25,000, to parties that are suspended or debarred. When a non-federal entity enters into a covered transaction, the non-federal entity must verify that the vendor is not suspended or debarred or otherwise excluded from participating in the transaction. This verification may be accomplished by (1) checking the System for Award Management (SAM) Exclusions maintained by the General Services Administration (GSA) and available at SAM.gov, (2) collecting a certification from the Vendor, or (3) adding a clause or condition to the covered transaction with that Vendor. University’s policies mirror the procurement policies as required by the Federal government, and defines a covered transaction as purchases exceeding $10,000. Condition In testing compliance with the suspension and debarment compliance requirement, 2 instances of 25 samples selected for testing were noted where the only evidence available to support the date of the performance of the required suspension and debarment checks was after the transaction date, as shown in the chart below. This is a repeat of prior year finding 2022-002. [table] Cause There are no questioned costs associated with this finding.The University uses Visual Compliance (VC) for suspension and debarment checks, which was implemented in 2019. Vendors onboarded prior to the implementation were registered and checked via a separate manual process within the procurement department. The above vendors were on-boarded and checked prior to the VC implementation; however, management could not provide evidence that the vendor check was performed prior to conducting business with the vendor due to the manual nature of the legacy process. Management has subsequently performed checks on these vendors and retained documentation of the checks to validate that the vendors are not currently suspended or debarred. Effect If procedures related to vendor suspended and debarred checks are not performed timely, there is a risk that the purchases could be made with a suspended or debarred vendor. Questioned Costs There are no questioned costs associated with this finding. Recommendation We recommend the University continue to follow its corrective action plan. Management’s View and Corrective Action Plan Management’s view and corrective action plan is included at the end of this report.